Accelerate Diagnostics Statistics
Share Statistics
Accelerate Diagnostics has 25.04M shares outstanding. The number of shares has increased by 23.54% in one year.
| Shares Outstanding | 25.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 5.76% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.25M |
| Failed to Deliver (FTD) Shares | 1.49K |
| FTD / Avg. Volume | 2.22% |
Short Selling Information
The latest short interest is 473.08K, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 473.08K |
| Short % of Shares Out | 1.89% |
| Short % of Float | 3.1% |
| Short Ratio (days to cover) | 7.77 |
Valuation Ratios
The PE ratio is -0.79 and the forward PE ratio is -1.15.
| PE Ratio | -0.79 |
| Forward PE | -1.15 |
| PS Ratio | 4.06 |
| Forward PS | 1.2 |
| PB Ratio | -2.46 |
| P/FCF Ratio | -1.19 |
| PEG Ratio | n/a |
Enterprise Valuation
Accelerate Diagnostics Inc. has an Enterprise Value (EV) of 75.99M.
| EV / Earnings | -1.23 |
| EV / Sales | 6.3 |
| EV / EBITDA | -1.53 |
| EV / EBIT | -1.41 |
| EV / FCF | -1.84 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of -1.85.
| Current Ratio | 2.03 |
| Quick Ratio | 1.76 |
| Debt / Equity | -1.85 |
| Total Debt / Capitalization | 217.4 |
| Cash Flow / Debt | -1.09 |
| Interest Coverage | -6.98 |
Financial Efficiency
Return on equity (ROE) is 3.1% and return on capital (ROIC) is -283.38%.
| Return on Equity (ROE) | 3.1% |
| Return on Assets (ROA) | -1.96% |
| Return on Capital (ROIC) | -283.38% |
| Revenue Per Employee | 89.99K |
| Profits Per Employee | -459.84K |
| Employee Count | 134 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.87 |
Taxes
| Income Tax | 850.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -61.84% in the last 52 weeks. The beta is 0.6, so Accelerate Diagnostics 's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -61.84% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 37.22 |
| Average Volume (20 Days) | 67.31K |
Income Statement
In the last 12 months, Accelerate Diagnostics had revenue of 12.06M and earned -61.62M in profits. Earnings per share was -4.94.
| Revenue | 12.06M |
| Gross Profit | 2.55M |
| Operating Income | -54.03M |
| Net Income | -61.62M |
| EBITDA | -49.77M |
| EBIT | -54.03M |
| Earnings Per Share (EPS) | -4.94 |
Balance Sheet
The company has 12.14M in cash and 39.22M in debt, giving a net cash position of -27.08M.
| Cash & Cash Equivalents | 12.14M |
| Total Debt | 39.22M |
| Net Cash | -27.08M |
| Retained Earnings | -668.86M |
| Total Assets | 32.31M |
| Working Capital | 9.18M |
Cash Flow
In the last 12 months, operating cash flow was -40.20M and capital expenditures -1.03M, giving a free cash flow of -41.23M.
| Operating Cash Flow | -40.20M |
| Capital Expenditures | -1.03M |
| Free Cash Flow | -41.23M |
| FCF Per Share | -3.3 |
Margins
Gross margin is 21.15%, with operating and profit margins of -448.03% and -510.97%.
| Gross Margin | 21.15% |
| Operating Margin | -448.03% |
| Pretax Margin | -503.92% |
| Profit Margin | -510.97% |
| EBITDA Margin | -412.73% |
| EBIT Margin | -448.03% |
| FCF Margin | -341.91% |
Dividends & Yields
AXDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -457.41% |
| FCF Yield | -152.44% |
Analyst Forecast
The average price target for AXDX is $1, which is -7.4% lower than the current price. The consensus rating is "Hold".
| Price Target | $1 |
| Price Target Difference | -7.4% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 12, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -34.1 |
| Piotroski F-Score | 4 |